A white man with salt and pepper hair gently smiles into the camera.

Nathan Lakey

Nathan Lakey is President and Chief Executive Officer of Orion Genomics, a company bringing cutting edge scientific expertise, innovation, proprietary technologies and commercial and academic partnerships throughout the globe to change how the world approaches feeding, fueling and healing itself. Lakey was awarded the top 40 under 40 award (2004 St. Louis), presented the governor’s top technology award (2005 Missouri), and he currently serves as Chairman of the Investment Advisory Committee, Biogenerator, and on the Patient Care Committee of the Board of Missouri Baptist Hospital. He has more than 20 years of experience in genomics. Prior to the founding of Orion Genomics, he was Director of DNA Sequencing at Millennium Pharmaceuticals, Inc., in Cambridge, Massachusetts (1994-98), where he built and operated Millennium’s DNA sequencing platform, and helped form three strategic business units – Millennium Predictive Medicine, Millennium Biotherapeutics and Cereon Inc. Before joining Millennium, Mr. Lakey held various positions with Molecular Dynamics (Sunnyvale, CA), Ambion Inc (Austin TX) and Harvard Medical School, Department of Genetics, in George Church’s laboratory. Mr. Lakey received a B.A. in Biochemistry from the University of Texas (Austin), and an MBA from Washington University Olin School of Business (St. Louis) where he received the C. William Emory Executive MBA Award. Mr. Lakey holds multiple issued patents in the U.S. and abroad.